comparemela.com

Latest Breaking News On - Pemphigus - Page 1 : comparemela.com

Pemphigus

Pemphigus is a rare group of autoimmune diseases that affect the skin and mucous membranes causing blisters and sores that fail to heal.

First-line rituximab for pemphigus associated with long-term complete remission rates

1. Patients with pemphigus treated with first-line rituximab showed sustained complete remission rates without corticosteroids for up to 7 years post-treatment 2. High-risk patients for pemphigus relapse could be assessed with enzyme-linked immunosorbent assay (ELISA) values of anit-Dsg antibodies. Evidence Rating Level: 1 (Excellent) Study Rundown: Pemphigus is a life-threatening rare autoimmune bullous disease affecting

Long-Term, Sustained Remission of Pemphigus Observed in Patients Treated with Rituximab

These data were the results of the secondary analysis of the Ritux 3 study, as the treatment’s short-term efficacy and safety had been confirmed previously.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.